Boston Scientific Corporation
BSX NYSEHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Jul 29, 2026
ET
EPS Est.
0.84
EPS Actual
0.86
Revenue Est.
$5.38B
Revenue Actual
$5.44B
Next Earnings Report
Date
Oct 28, 2026 · Wed
ET Oct 28, 2026 · Wed
Time
10/28 10:00-13:30
Pre-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
0.77
Revenue Est.
$5.18B
Company Overview
Boston Scientific Corporation (ticker BSX) is listed on NYSE with a market cap of about $63.32B. Its next earnings report (FY2026 Q3) is expected on Oct 28, 2026 (ET), Pre-market, with consensus EPS of 0.77. In the last 15 reported quarters, EPS beat consensus estimates 14 times.
Actual EPS TrendRecently15Term · Feb 1, 2023 → Jul 29, 2026
Feb 1, 2023Range: 0.45 ~ 0.86Jul 29, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 29, 2026 | -- | 0.84 | Above forecast↑0.86 | $5.38B | $5.44B |
| Apr 22, 2026 | -- | 0.79 | Above forecast↑0.80 | $5.17B | $5.2B |
| Feb 4, 2026 | -- | 0.78 | Above forecast↑0.80 | $5.28B | $5.29B |
| Oct 22, 2025 | -- | 0.71 | Above forecast↑0.75 | $4.97B | $5.07B |
| Jul 23, 2025 | -- | 0.73 | Above forecast↑0.75 | $4.89B | $5.06B |
| Apr 23, 2025 | -- | 0.67 | Above forecast↑0.75 | $4.57B | $4.66B |
| Feb 5, 2025 | -- | 0.66 | Above forecast↑0.70 | $4.42B | $4.56B |
| Oct 23, 2024 | -- | 0.59 | Above forecast↑0.63 | $4.04B | $4.21B |
| Jul 24, 2024 | -- | 0.58 | Above forecast↑0.62 | $4.03B | $4.12B |
| Apr 24, 2024 | -- | 0.51 | Above forecast↑0.56 | $3.68B | $3.86B |
| Jan 31, 2024 | -- | 0.51 | Above forecast↑0.55 | $3.59B | $3.73B |
| Oct 26, 2023 | -- | 0.48 | Above forecast↑0.50 | $3.47B | $3.53B |
| Jul 27, 2023 | -- | 0.49 | Above forecast↑0.53 | $3.5B | $3.6B |
| Apr 26, 2023 | -- | 0.43 | Above forecast↑0.47 | $3.16B | $3.39B |
| Feb 1, 2023 | -- | 0.47 | Below forecast↓0.45 | $3.24B | $3.24B |
Original Filings (SEC)
Quarterly10-Q · 2026-08-03 ↗
Earnings Release8-K · 2026-07-29 ↗
Earnings Release8-K · 2026-04-22 ↗
Annual10-K · 2026-02-17 ↗
Earnings Release8-K · 2026-02-04 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website. For some foreign private issuers (ADRs), the earnings filing is typically submitted to the SEC several days after the results are announced; it will appear here automatically once filed.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
